Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Marc S. Raab, Hongfang Wang et al.|Cells|2024Cited by 18
P-266 Pre-clinical characterization of SAR442257, a CD38xCD28xCD3 trispecific T-cell engager in relapsed/refractory multiple myelomaAnna Luise Grab, Marc S. Raab, Peter Kim et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0